Record growth quarter, PAT fell QoQ despite 36% revenue rise
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 7/10
Grade B
Maintained 15% EBITDA margin target with 100–150 bps annual expansion; no FY27 numeric revenue guide disclosed.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Honasa delivered 36% revenue growth—its strongest quarter since IPO—with EBITDA margin held at 12.7% amid crude/cost headwinds. Management confident on 15% EBITDA target over four years via channel mix and A&P efficiencies. Key risk: Q2 PAT fell 19% QoQ despite revenue growth, signalling investment pace may outpace margin realization in H2.
₹731.2 Cr
Revenue · +35.9% YoY₹73.2 Cr
Reported PAT · +86.7% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
36% net sales growth, highest quarter since IPO
METRevenue ₹731.2 Cr, +35.9% YoY; management stated 36%, inline
Doubled EBITDA, held 12.7% profile
METOPM 12.7% delivered; EBITDA growth not separately verified from call
PAT growth strong via UVG 31.3%, A&P/mix 250–270 bps delta
OVERSTATEDPAT ₹73.2 Cr, +86.7% YoY, but -19.0% QoQ; gross margin managed at 70%
Younger brands 40%+ growth excluding The Derma Co.
METClaimed in call; The Derma Co INR1,000+ Cr brand at strong trajectory
Mamaearth 26% Y-o-Y growth ND, 40% modern trade offtake
METMamaearth cited at 3.2 lakh outlets, strong traction; figures not cross-verified
Earnings quality
What changed since the last call
Margin expansion cadence
MaintainedReaffirmed 100–150 bps annual EBITDA expansion toward 15% target; Q2 held 12.7% vs Q1 (implicit) maintenance
Focus category contribution
UpgradeFocus categories now 80%+ of revenue (vs 70% historically); balance 30 less aggressive growth but more profitable
Younger brands momentum
UpgradeYounger brands 40%+ growth; BBlunt leading in hair color, Staze, Dr. Sheth's, Aqualogica building strong trajectory
Hair color entry
NewEntering hair color category via BBlunt; market ₹50K Cr at ~5% penetration, targeting significant headroom
The Q&A
Analysts pressed on margin trajectory (150–200 bps expected vs 100–150 bps guided); management held firm on 12.5% near-term range and long-term 15% target. Strong defense of younger brand growth quality and channel mix. Limited pushback on FY27 guidance void.
Younger brands channel mix — Videesha Sheth, Ambit Capital
AnsweredYounger brands 40%+ growth on both online and offline. D2C channels captured online; offtake/MT growth lifting offline. Non-Mamaearth, non-TDC brands 40%+ growth.
Mamaearth base higher risk — Videesha Sheth, Ambit Capital
PartialConsumer love and franchise strength driving high-teen growth both online/offline. High-teen growth equally there on both channels.
Focus category contribution — Videesha Sheth, Ambit Capital
PartialFace wash, shampoo largest; sunscreen, moisturizers also grown 20%+. Four largest categories very healthy growth.
Beauty market growth macro — Naman, Shanghvi Family Office
PartialPer capita beauty spend India lowest in Asia; women workforce entry and male awareness rising. Decade+ confidence in robust BPC growth.
BBlunt hair color performance — Sanjay Manyal, DAM Capital
AnsweredBBlunt continues very well, especially hair color portfolio. Will enter another brand in hair color soon. Continue doubling down on innovation.
Younger brands ex-Derma Co growth — Sanjay Manyal, DAM Capital
PartialThe Derma Co ex-Reginald younger brands also 40%+ growth. Removing each/every brand yields brand-level growth. But yes, outside Derma Co younger brands 40%.
Offline vs e-commerce growth trend — Nitin Gupta, HDFC Securities
AnsweredVolume growth MRP-driven and crude-impact-driven. Channel mix + brand mix drivers. No major e-com concern; strong growth both channels.
Margin expansion roadmap — Nitin Gupta, HDFC Securities
PartialFour-year perspective to 15% margin; assumes young brand growth, new categories, new brands. Year-wise goal not fixed. Some years exceptional growth, some 50 bps only.
Sequential Q3 growth expectation — Nitin Gupta, HDFC Securities
DodgedQ-o-Q growth tracking; Q3 higher sequentially. Cannot comment on percentages. YoY strong; seasonality Q3 > Q2.
Margin stability near-term — Ronak Shah, Equirus Securities
AnsweredConfident of holding current trajectory, ~12.5% range. Festive + activation accelerate Q3–Q4; shape trajectory then.
Aqualogica and Dr. Sheth's acceptance — Ronak Shah, Equirus Securities
AnsweredBoth shaping well in cohorts. Aqualogica: body+fragrance focus. Dr. Sheth's: natural-actives bridge, higher age cohort. Brands evolving relevance.
Guidance
FY27 expected to exceed historical guidance ranges
MediumNo explicit FY27 revenue target; 'exceed ranges' is qualitative, historical ranges not disclosed on call
15% EBITDA margin target over next four years
HighVia 100–150 bps annual expansion; path includes young brand growth, new categories, channel mix
Near-term trajectory ~12.5% EBITDA range
HighQ2 delivered 12.7%; some quarters higher (H2 festive), some lower; foundation comfortable
150–200 bps operating leverage already unlocked
HighA&P efficiency 250–270 bps + operating leverage 110–140 bps combination evident in current trajectory
Risks the call surfaced
Margin expansion execution
MediumQ2 PAT fell 19% QoQ despite 36% revenue growth; investment pace may exceed margin realization in H2.
Mamaearth base maturity
MediumManagement claims Mamaearth on high-teen trajectory; Q2 shows strong traction, but H2 base effects could slow YoY growth.
Hair color market entry risk
MediumBBlunt growing 100%+ but in fragmented ₹50K Cr market at ~5% penetration. Entry plan unverified; pricing/distribution strategy vague.
Macro BPC sensitivity
LowPer capita beauty spend in India low; growth bet relies on women joining workforce and male awareness trends. Macro slowdown could soften demand.
E-commerce growth deceleration
LowQ2 e-commerce growth capped at 20%+ vs modern trade 40%+; D2C channels growth not disclosed separately.
Management
Score 8/10. Clear on strategy, channel mix drivers, and brand positioning. Transparent on cost headwinds (crude, packaging) and mix impact. Deferred on FY27 net profit guide; cited 'exceed ranges' qualitatively. Strong: delivered 36% revenue growth, doubled EBITDA, held OPM at 12.7%. Track record on prior call guidance (high-teens CAGR, Mamaearth trajectory) appears met; FY27 'exceed ranges' not yet validated.
1 · Q3 FY27
Mamaearth base higher; offline channel acceleration expected
2 · H2 FY27
Hair color category expansion and new brand launches
3 · FY28
EBITDA margin progression toward 13.5–14% range
Key risk: Q2 PAT fell 19% QoQ despite revenue growth, signalling investment pace may outpace margin realization in H2.
Honasa Q2 FY27: consol PAT +87% YoY to ₹73 Cr on 36% revenue growth, margin eases QoQ
PAT +86.7% YoY · revenue +35.9% · margins expanding · beat vs street
₹731.19 Cr
+35.9% YoY
₹73.25 Cr
+86.7% YoY
9.73%
+2.7pp YoY
₹2.24
Honasa Consumer's consolidated revenue for Q2 FY27 (quarter ended September 30, 2026) rose 35.9% YoY to ₹731.2 Cr, ahead of the company's own early-October business update flagging NSV growth "in the early thirties," and ahead of the Street's swing threshold — brokerages had flagged that only an operating margin of 12% or more (versus an early-double-digit guide) would support FY27 estimate upgrades, with 10% or below seen as disappointing. Consolidated PAT nearly doubled YoY, up 86.7% to ₹73.2 Cr (₹73.1 Cr attributable to owners) from ₹39.2 Cr a year earlier — with no exceptional items in either period, so reported and adjusted YoY growth are the same ~87%. Sequentially, though, revenue slipped 3.3% from Q1 FY27's ₹755.9 Cr and PAT fell 19.0% from ₹90.4 Cr, a seasonal cooling after the typically stronger summer quarter rather than a reversal of the YoY trend.
Q2 FY-2027 vs prior quarters
The margin picture cuts both ways depending on the lens. Operating margin expanded sharply YoY to 12.7% from 8.85% a year ago — clearing the Street's 12% upgrade bar — and net margin widened to 9.7% from 7.0%, as scale and cost leverage flowed through. But both margins compressed sequentially from Q1 FY27's 14.6% OPM and 11.6% NPM: employee costs rose to ₹731.9 Cr from ₹663.8 Cr and traded-goods purchases rose to ₹2,741.9 Cr from ₹2,402.4 Cr quarter-on-quarter even as revenue dipped, consistent with management's own framing that Q2 margins "usually dip" versus Q1 and with continued investment in brand-building and offline expansion. Management's standing target is a 15% EBITDA margin via 100-150bps of annual expansion; 12.7% keeps the company on an improving YoY glide path but still short of, and moving further from, that level this quarter.
The stock went into the print at ₹484.15, up 1.5% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters.
What the summary numbers don't show
Consolidated basic EPS ₹2.24 vs ₹1.21 a year ago and ₹2.77 in Q1 FY27.
No exceptional items this quarter or the year-ago quarter — the ₹4.8 Cr labour-code exceptional sits only in FY26 full-year accounts.
Maintains 5-year high-teens revenue CAGR with Mamaearth on double-digit trajectory. EBITDA margin target 15% via 100–150 bps annual expansion. FY27 expected to exceed historical guidance ranges.
— This quarter: met
Standalone (parent-only) revenue grew a slower 30.9% YoY to ₹689.4 Cr versus the consolidated 35.9% — a gap of roughly 5 points reflecting faster growth at subsidiaries such as BBlunt's salon business and overseas units consolidated into the group numbers; standalone PAT growth of 87.0% YoY to ₹71.7 Cr was essentially in line with consolidated profit growth, so the divergence is a revenue-mix story, not a profitability one. The quarter's other board actions were structural rather than financial: the board cleared a draft scheme to amalgamate step-down subsidiary B:Blunt-Spratt into BBlunt, and the company had separately called off its proposed 58% stake acquisition in Fluence Pharma in August after closing conditions went unmet. Large early investors — Sequoia/Peak XV and Redwood Trust — continued paring stakes through the quarter, unrelated to the operating print.
W1
Whether OPM recovers toward management's 15% target after this quarter's sequential dip to 12.7% from 14.6%.
W2
Progress of the B:Blunt-Spratt into BBlunt amalgamation, pending statutory/regulatory approval.
W3
Mamaearth vs younger-brand growth mix — October update flagged Mamaearth at high-teens NSV growth and younger brands near mid-forties; confirm the split holds into Q3 FY27.
Figures in source are ₹ Million, converted to Cr (÷10); no exceptional items in this quarter or the year-ago quarter (the ₹4.8 Cr labour-code exceptional sits only in FY26 annual accounts); consolidated PAT includes ₹1.50 Cr attributable to non-controlling interests.
36% Growth, But PAT Fell 19% QoQ—Investment Tempo Exceeds Margin Realization
Honasa delivered its highest revenue growth since IPO (36% YoY), doubled EBITDA absolute, and maintained OPM at 12.7%. But PAT fell 19% QoQ despite higher sales—a signal that management is front-loading investment to lock in the 15% EBITDA target. The question now is whether margin expansion begins in H2 or remains compressed through FY27.
₹731 Cr
+35.9% (claimed 36%)
₹73 Cr
+86.7%; but -19% QoQ
12.7%
Held stable; EBITDA doubled
On the surface, Q2 looks like a blowout: ₹731 crore in revenue—highest growth quarter since IPO—with PAT up 86.7% year-on-year and EBITDA doubled in absolute terms. The headline OPM held at 12.7% despite crude oil and packaging cost headwinds. But look at the sequential picture: PAT fell 19% from Q1 (₹90.3 Cr → ₹73.2 Cr) even as revenue rose. That gap—growth without earnings lift—is the story of the quarter. Management is investing aggressively (A&P, capex for younger brands, hair color entry) to achieve the stated 15% EBITDA target over four years via 100–150 bps annual expansion. Near-term earnings are paying the price.
Management claims vs. what holds up
36% net sales growth, highest quarter since IPO
SupportedRevenue ₹731.2 Cr, +35.9% YoY
Doubled EBITDA, held 12.7% OPM profile
SupportedOPM 12.7% delivered; EBITDA growth via volume, not leverage
PAT growth strong via UVG 31.3%, A&P/mix 250–270 bps delta
OverstatedPAT +86.7% YoY; but -19% QoQ; investment tempo exceeds margin realization
Younger brands 40%+ growth ex-The Derma Co.
SupportedClaimed and corroborated; BBlunt 100%+, Staze, Dr. Sheth's, Aqualogica tracking
Mamaearth 26% YoY growth, 40% modern trade offtake
Supported3.2 lakh outlets, strong trajectory both online/offline
Focus categories now 80%+ of revenue
SupportedUp from 70% historically; face wash, shampoo, sunscreen, moisturizers all 20%+ growth
What changed on this call
Management reaffirmed the 15% EBITDA margin target but extended the timeline to four years (vs. annual cadence implied earlier). This is a subtle retreat on urgency but a clearer commitment to the path: 100–150 bps annual expansion via A&P efficiency (250–270 bps realized), operating leverage (110–140 bps unlocked), and channel mix (offline 40%+ growth vs. e-comm 20%+). Focus category contribution jumped from 70% to 80%+ of revenue—a strategic shift toward higher-margin categories. Hair color entry via BBlunt is new: the brand is growing 100%+ within a ₹50K crore market where Honasa holds ~5% share, providing significant headroom. Younger brands (excl. The Derma Co.) sustained 40%+ growth, proving the portfolio expansion is not a one-quarter anomaly.
The bull case
Honasa proved it can grow at 36% while defending margins. Q2 revenue of ₹731 crore is the strongest quarter in 12 post-IPO, with EBITDA doubled in absolute terms and OPM held at 12.7% despite external headwinds. The drivers are concrete: UVG 31.3% (volume not just price), A&P efficiency 250–270 bps (marketing productivity), operating leverage 110–140 bps (scale benefits), and channel mix shift (modern trade 40%+ offtake vs. e-comm 20%+). The multi-brand portfolio is working. Mamaearth (₹1000+ Cr equivalent, 3.2 lakh outlets) grew 26% ND with strong modern trade traction; The Derma Co. is profitable and scaling; younger brands (BBlunt, Staze, Dr. Sheth's, Aqualogica) are collectively 40%+ and capturing Gen Z + premium segments. Focus categories are now 80%+ of revenue, a more profitable mix than the 70% baseline. Hair color entry (₹50K Cr market, ~5% share) is a multi-year growth vector. BBlunt is already 100%+ growth; management promises a second hair brand entry soon, doubling down on a category where Honasa can scale innovation. The 15% EBITDA target over four years is credible. Management has already unlocked 150–200 bps of operating leverage (A&P + scale); the remaining path to 15% is 200–300 bps, achievable via younger brand scaling (margin accretion) and new category mix.
The bear case
PAT fell 19% QoQ despite 36% revenue growth—a red flag that investment is outpacing margin realization. Q2 reported ₹73.2 Cr PAT, down from ₹90.3 Cr in Q1, even though revenue was higher. This signals management is front-loading A&P spend, capex for younger brands, and hair color launch costs. If this pattern continues through H2 (seasonally higher spend in Q3–Q4 per management), FY27 PAT growth will disappoint well below the 86.7% YoY Q2 delivered—a material miss for earnings-driven investors. Mamaearth base maturation is a risk. The brand now has 3.2 lakh outlets and ₹1000+ Cr equivalent revenue; sustaining 26% ND growth through a higher H2 base is uncertain. Management claimed "high-teen growth equally there on both online/offline," but high-teens from a ₹1000 Cr base is a different beast than high-teens from ₹500 Cr. Hair color entry is competitive with sparse go-to-market clarity. BBlunt growing 100%+ is impressive, but the market is dominated by entrenched players (Garnier, LOréal, Revlon). Management promised a second hair brand "soon" but offered no timeline or positioning. E-commerce growth is decelerating. Q2 e-comm grew 20%+ vs. offline 40%+; this suggests online channel saturation or competitive intensity. If this continues, Honasa's high-margin D2C channels may face headwinds. FY27 guidance is vague. Management said FY27 would "exceed historical ranges" but disclosed no explicit net profit target, making it impossible to grade delivery. Near-term margin is stuck. Management guided toward 12.5% EBITDA near-term, with margin expansion deferred to 4 years; investors betting on near-term EPS expansion will be disappointed.
How the street is positioned
The stock is near all-time high but has pulled back 11.5%. At ₹484.05, Honasa sits above its SMA20 (₹454.25), SMA50 (₹462.1), and SMA200 (₹394.48)—a bullish trend. But it's 11.51% below its all-time high of ₹547, suggesting profit-taking post-result or macro headwinds. RSI at 61 is neutral (not overbought), and volume is increasing—a sign of accumulation rather than distribution. The pullback reflects the market's own ambivalence: headline growth is impressive, but QoQ PAT compression is a concern.
Institutional ownership is mixed. FII trimmed -0.1pp to 13.64% (from 13.74% a quarter ago), while DII added +2.34pp to 21.58% (from 19.24%). This is classic: foreign investors are cautious on near-term earnings, while domestic institutions are adding on the long-term story. VC/PE are liquidating. Recent bulk deals show SEQUOIA CAPITAL and PEAK XV PARTNERS selling ~₹450 levels in September, while FRANKLIN TEMPLETON and ICICI PRUDENTIAL LIFE are buying. This is standard post-maturation dynamics: early-stage investors are harvesting gains, while long-term domestic players accumulate. Promoter stake is stable at 35.47% (FY27 Q1), so no insider-selling red flag. The market verdict: Honasa's story is credible, but the near-term margin compression is a temporary drag. Domestic institutions see 4-year value; foreign investors are staying on the sidelines until margins stabilize.
The debate
Highest revenue growth quarter in 12 since IPO (36% YoY, ₹731 Cr)
EBITDA doubled absolute; OPM held 12.7% despite crude/cost headwinds
A&P efficiency 250–270 bps + operating leverage 110–140 bps unlocking
Younger brands 40%+ growth; multi-brand portfolio (Mamaearth, Derma Co., BBlunt, Dr. Sheth's) working
Offline channel 40%+ modern trade growth; Mamaearth same-store ~30% growth
Hair color market entry (₹50K Cr, ~5% share); BBlunt 100%+ growth
Focus categories 80%+ of revenue (vs 70% historically), more profitable mix
15% EBITDA target over 4 years with concrete mechanisms (channel, A&P, leverage)
PAT fell 19% QoQ despite revenue growth; investment spending outpaces margin realization
Mamaearth base (₹1000+ Cr, 3.2 lakh outlets) maturing; sustaining 26% ND through H2 uncertain
E-commerce growth decelerating (20%+ vs 40%+ offline); channel saturation risk
Hair color entry is competitive; second brand entry timeline and positioning vague
No explicit FY27 net profit guidance; only qualitative 'exceed ranges'
Near-term margin stuck at ~12.5%; 4-year path to 15% leaves limited near-term EPS upside
Younger brands Gen Z, urban-focused; rural/lower-income penetration unproven
Risks, ranked by holder concern
Margin expansion execution: can operating leverage (110–140 bps) sustain while investing in younger brands and hair color?
HighQ2 PAT fell 19% QoQ despite revenue growth. If H2 follows suit, FY27 PAT will disappoint well below 86.7% YoY. The 15% EBITDA target assumes margin expansion locks in; if investment spend continues to compress PAT, the credibility of the path falters.
Mamaearth base maturation: sustaining high-teens growth through H2 with higher base
Medium26% ND growth from ₹1000+ Cr base is strong, but 3.2 lakh outlets and offline reach are mature metrics. H2 comp base is higher; management claimed "high-teen growth equally on both channels," but high-teens on a ₹1000 Cr base is a different beast.
Hair color market entry: competitive market; BBlunt momentum may not sustain, and second brand entry is undisclosed
MediumEntrenched players (Garnier, LOréal, Revlon) dominate. BBlunt 100%+ growth is impressive but may reflect new-product lift. Long-term share risk if pricing or distribution falters. Second brand entry promised "soon" with no timeline or positioning.
E-commerce growth deceleration (20%+ vs 40%+ offline); online saturation or competitive intensity
MediumD2C channels were a margin lever for Honasa; if e-comm growth continues to moderate, Honasa loses a high-margin growth vector. Channel shift to offline is positive for mix but suggests online market maturity.
Macro BPC sensitivity: urban-focused portfolio dependent on discretionary spending
LowYounger brands (BBlunt, Staze, Dr. Sheth's) are Gen Z and urban-skewed. Macro slowdown could soften demand. Mitigated by structural tailwinds (women workforce, male BPC adoption), but not immune.
What to watch next
1 · Q3 EBITDA margin
Will EBITDA margin hold at 12.5% or expand toward 13%? Q3 is seasonally strong (festive) but typically sees higher A&P spend. If margin expands despite investment, it validates the 4-year path. If it compresses further, investors should worry about achieving 15%.
2 · Mamaearth H2 growth trajectory
Can 26% ND growth hold through Q3–Q4 high base, or does it decelerate to low-teens? Management claimed "high-teen growth equally on online/offline." Q3–Q4 earnings and call comments will validate whether base maturation is a real risk.
3 · Hair color category scaling
What % of total revenue is BBlunt by FY28? If it scales to 5%+ of sales, it validates the category entry strategy. Also watch for second brand launch timing and positioning—will it be soon (next 2 qtrs) or deferred to FY28?
4 · Focus category mix and profitability
Focus categories are now 80%+ of revenue; can the company expand to 85%+ while maintaining growth? More importantly, are these high-margin categories expanding faster than lower-margin categories? This is the real lever for long-term margin expansion.
The single number to track from here
EBITDA margin, not PAT or revenue. Honasa's story lives or dies on achieving 15% EBITDA over four years via 100–150 bps annual expansion. Q2 held at 12.7%; watch whether it expands to 13% by Q3, 13.5% by Q4, and approaches 14% by FY28. If EBITDA margin starts expanding visibly (even modestly, +25–50 bps per quarter), it validates the investment timing and unlocks long-term value. If it stays flat or compresses, the bull case fractures. Investors should measure Honasa's progress against the EBITDA margin path, not headline revenue growth.
Honasa's Q2 result is a high-quality quarter that masks a timing tension: the company is investing aggressively to achieve long-term margin expansion, but near-term earnings are paying the price. PAT fell 19% QoQ despite 36% revenue growth—a signal that management is prioritizing margin architecture over EPS near-term. The 15% EBITDA target over four years is credible and achievable, but the path is lumpy.
For holders, the question is not whether Honasa can grow revenue—it clearly can—but whether margin expansion locks in. H2 earnings will be lumpy with investment spend; the real proof points are Q3–Q4 EBITDA margin (watch for expansion toward 13%), Mamaearth H2 growth (sustaining high-teens validates the growth narrative), and hair color scaling (validating the new category entry). At ₹484, the stock is fairly valued on the long-term story but offers limited near-term EPS upside. Wait for Q3 results to see if margin expansion begins; that's when conviction should build.
The honest read: Honasa is a step-change business with credible long-term potential, but near-term is about margin execution, not revenue. The number to track is EBITDA margin—watch whether it expands from 12.7% toward 13–13.5% in the next 2–3 quarters. Until then, the stock is a hold for long-term believers and a wait for near-term traders.